Analyst firms · DZ Bank · LLY

DZ Bank LLY price target and rating history

Eli Lilly and Company (LLY) · Health Care

DZ Bank rates Eli Lilly and Company (LLY) Hold with a $820 price target, as of its latest action on Feb 21, 2024. It has published 3 rating actions on LLY since August 2021, including 2 upgrades and 1 downgrade. Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.

Current rating
Hold
Price target
$820
Median target, all firms
$1,250
Actions on LLY
3

DZ Bank price target on LLY

$820$554$28820222023202420252026
DZ Bank price target on LLY, each point a stated target, August 2021 to February 2024.

Every DZ Bank rating on LLY

How other firms rate LLY

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BerenbergBuy$1,400Sep 15, 2026
HSBCReduce$850Mar 17, 2026
RBC Capital MarketsOutperform$1,250Feb 25, 2026
BarclaysOverweight$1,350Feb 20, 2026
UBSBuy$1,250Jan 7, 2026
DaiwaBuy$1,230Dec 16, 2025
Goldman SachsBuy$1,145Dec 15, 2025
BofA SecuritiesBuy$1,268Dec 15, 2025

Questions about DZ Bank and LLY

What is DZ Bank's price target for LLY?
DZ Bank's latest stated price target for Eli Lilly and Company (LLY) is $820, from its action on Feb 21, 2024.
What is DZ Bank's rating on LLY?
DZ Bank rates LLY Hold, a neutral rating, as of Feb 21, 2024.
When did DZ Bank last change its view on LLY?
On Feb 21, 2024, DZ Bank downgrades to Hold from Buy, price target $820.
How does DZ Bank's LLY target compare with other analysts?
Across 8 firms with a LLY price target in the last 12 months, the median target is $1,250.

More LLY rating histories

All DZ Bank ratingsLLY news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.